← Insider buys
RCUS

Arcus Biosciences, Inc. · Healthcare

COO Jennifer Jarrett sold $507K of Arcus Biosciences, Inc.

Sold$506,822
$30.75Price
16,482Shares
−10%Stake

What RCUS did after the filing

Filed Dec 16Copier in Dec 19
The stock from Mon, Dec 19 open, $30.65
−31.0%
S&P 500, same days
+8.7%

Measured over 30 trading days, to the Feb 2 close.

Traded Fri, Dec 16. Filed Fri, Dec 16, 9:41 PM ET, after the close. Returns use the Dec 19 open and the Feb 2 close. Not investment advice.